These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 32281532)
1. Fabry Disease Screening in Patients With Kidney Transplant: A Single-Center Study in Turkey. Erdogmus S; Kutlay S; Kumru G; Ors Sendogan D; Erturk S; Keven K; Ceylaner G; Sengul S Exp Clin Transplant; 2020 Aug; 18(4):444-449. PubMed ID: 32281532 [TBL] [Abstract][Full Text] [Related]
2. [Screening Test of Fabry Disease in Patients with Renal Replacement Therapy in the City of Modena]. Alfano G; Ganda N; Cerami C; Mori G; Fontana F; Cappelli G G Ital Nefrol; 2018 Mar; 35(2):. PubMed ID: 29582965 [TBL] [Abstract][Full Text] [Related]
3. Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: identification of new case with novel mutation. Okur I; Ezgu F; Biberoglu G; Tumer L; Erten Y; Isitman M; Eminoglu FT; Hasanoglu A Gene; 2013 Sep; 527(1):42-7. PubMed ID: 23756194 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of Fabry Disease in Familial Mediterranean Fever Patients from Central Anatolia of Turkey. Huzmeli C; Candan F; Alaygut D; Bagci G; Akkaya L; Bagci B; Sozmen EY; Kurtulgan HK; Kayatas M Biochem Genet; 2016 Aug; 54(4):448-456. PubMed ID: 27105876 [TBL] [Abstract][Full Text] [Related]
5. Fabry Disease Prevalence in Renal Replacement Therapy in Turkey. Yalın SF; Eren N; Sinangil A; Yilmaz VT; Tatar E; Ucar AR; Sevinc M; Can Ö; Gurkan A; Arik N; Alisir Ecder S; Uyar M; Yasar M; Gulcicek S; Mese M; Dheir H; Cakir U; Köksal Cevher Ş; Turkmen K; Guven B; Guven Taymez D; Erkalma Senates B; Ecder T; Kocak H; Uslu A; Demir E; Basturk T; Ogutmen MB; Kinalp C; Dursun B; Bicik Bahcebasi Z; Sipahi S; Dede F; Oruc M; Caliskan Y; Genc A; Yelken B; Altıparmak MR; Turkmen A; Seyahi N Nephron; 2019; 142(1):26-33. PubMed ID: 30739116 [TBL] [Abstract][Full Text] [Related]
6. Preliminary Screening Results of Fabry Disease in Kidney Transplantation Patients: A Single-Center Study. Yılmaz M; Uçar SK; Aşçı G; Canda E; Tan FA; Hoşcoşkun C; Çoker M; Töz H Transplant Proc; 2017 Apr; 49(3):420-424. PubMed ID: 28340804 [TBL] [Abstract][Full Text] [Related]
7. Two-tier approach for the detection of alpha-galactosidase A deficiency in kidney transplant recipients. De Schoenmakere G; Poppe B; Wuyts B; Claes K; Cassiman D; Maes B; Verbeelen D; Vanholder R; Kuypers DR; Lameire N; De Paepe A; Terryn W Nephrol Dial Transplant; 2008 Dec; 23(12):4044-8. PubMed ID: 18596132 [TBL] [Abstract][Full Text] [Related]
8. Screening Fabry's disease in chronic kidney disease patients not on dialysis: a multicenter study. Yeniçerioğlu Y; Akdam H; Dursun B; Alp A; Sağlam Eyiler F; Akın D; Gün Y; Hüddam B; Batmazoğlu M; Gibyeli Genek D; Pirinççi S; Ersoy İR; Üzüm A; Soypaçacı Z; Tanrısev M; Çolak H; Demiral Sezer S; Bozkurt G; Akyıldız UO; Akyüz Ünsal Aİ; Ünübol M; Uslu M; Eryılmaz U; Günel C; Meteoğlu İ; Yavaşoğlu İ; Ünsal A; Akar H; Okyay P Ren Fail; 2017 Nov; 39(1):104-111. PubMed ID: 27832731 [TBL] [Abstract][Full Text] [Related]
9. Newborn screening for Fabry disease in the north-west of Spain. Colon C; Ortolano S; Melcon-Crespo C; Alvarez JV; Lopez-Suarez OE; Couce ML; Fernández-Lorenzo JR Eur J Pediatr; 2017 Aug; 176(8):1075-1081. PubMed ID: 28646478 [TBL] [Abstract][Full Text] [Related]
10. A novel small insertion mutation, C.1030_1031ins (T) in α-galactosidase A leads to renal variant fabry disease. Choi JS; Kim CS; Park JW; Bae EH; Ma SK; Choi YD; Kim GH; Yoo HW; Kim SW Ren Fail; 2012; 34(3):390-3. PubMed ID: 22260214 [TBL] [Abstract][Full Text] [Related]
11. The D313Y variant in the GLA gene - no evidence of a pathogenic role in Fabry disease. Hasholt L; Ballegaard M; Bundgaard H; Christiansen M; Law I; Lund AM; Norremolle A; Krogh Rasmussen A; Ravn K; Tumer Z; Wibrand F; Feldt-Rasmussen U Scand J Clin Lab Invest; 2017 Dec; 77(8):617-621. PubMed ID: 29037082 [TBL] [Abstract][Full Text] [Related]
12. Ratio of Fabry disease in patients with idiopathic left ventricular hypertrophy: A single-center study in Turkey. Barman HA; Özcan S; Atıcı A; Özgökçe C; Öztürk A; Kafalı AE; Çakar NE; Tavşanlı ME; Küçük M; Şahin I; Okuyan E Anatol J Cardiol; 2020 Jan; 23(2):79-85. PubMed ID: 32011328 [TBL] [Abstract][Full Text] [Related]
13. A Novel Missense GLA Mutation (p.G35V) Detected in Hemodialysis Screening Leads to Severe Systemic Manifestations of Fabry Disease in Men and Women. Veloso VSP; Ataides TL; Canziani MEF; Veloso MP; da Silva NA; Barreto DV; Pereira ERS; de Moura LAR; Barreto FC Nephron; 2018; 138(2):147-156. PubMed ID: 28892806 [TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and mutation spectrum of GLA in Korean patients with Fabry disease by a nationwide survey: Underdiagnosis of late-onset phenotype. Choi JH; Lee BH; Heo SH; Kim GH; Kim YM; Kim DS; Ko JM; Sohn YB; Hong YH; Lee DH; Kook H; Lim HH; Kim KH; Kim WS; Hong GR; Kim SH; Park SH; Kim CD; Kim SM; Seo JS; Yoo HW Medicine (Baltimore); 2017 Jul; 96(29):e7387. PubMed ID: 28723748 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy. Terryn W; Deschoenmakere G; De Keyser J; Meersseman W; Van Biesen W; Wuyts B; Hemelsoet D; Pascale H; De Backer J; De Paepe A; Poppe B; Vanholder R Int J Cardiol; 2013 Sep; 167(6):2555-60. PubMed ID: 22805550 [TBL] [Abstract][Full Text] [Related]
16. Higher rate of rheumatic manifestations and delay in diagnosis in Brazilian Fabry disease patients. Rosa Neto NS; Bento JCB; Pereira RMR Adv Rheumatol; 2020 Jan; 60(1):7. PubMed ID: 31907047 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive clinical evaluation of a large Spanish family with Anderson-Fabry disease, novel GLA mutation and severe cardiac phenotype. San Román-Monserrat I; Moreno-Flores V; López-Cuenca D; Rodríguez-González-Herrero E; Guillén-Navarro E; Rodríguez-González-Herrero B; Alegría-Fernández M; Poza-Cisneros G; Piñero-Fernández JA; Sornichero-Martínez J; Gimeno-Blanes JR Med Clin (Barc); 2014 Jun; 142(11):497-504. PubMed ID: 24679964 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel mutation and prevalence study for fabry disease in Japanese dialysis patients. Nishino T; Obata Y; Furusu A; Hirose M; Shinzato K; Hattori K; Nakamura K; Matsumoto T; Endo F; Kohno S Ren Fail; 2012; 34(5):566-70. PubMed ID: 22563919 [TBL] [Abstract][Full Text] [Related]
19. Anderson-Fabry disease: a case-finding study among male kidney transplant recipients in Austria. Kleinert J; Kotanko P; Spada M; Pagliardini S; Paschke E; Paul K; Voigtländer T; Wallner M; Kramar R; Stummvoll HK; Schwarz C; Horn S; Holzer H; Födinger M; Sunder-Plassmann G Transpl Int; 2009 Mar; 22(3):287-92. PubMed ID: 18954370 [TBL] [Abstract][Full Text] [Related]
20. Targeted Screening of Fabry Disease in Male Hemodialysis Patients in Brazil Highlights Importance of Family Screening. Silva CA; Barreto FC; Dos Reis MA; Moura Junior JA; Cruz CM Nephron; 2016; 134(4):221-230. PubMed ID: 27576502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]